#235Extended selection 101–300
Resilience Biotechnologies
Canada · Canada
API / CDMO / synthesisBiologics
Manufacturing profile
API / CDMO / synthesis
Biologics
Country: Canada
Macro-region: Canada
Selection basis
The company is placed in positions 101–300 as a manufacturer, biotech, specialty-pharma, generics or CDMO company with practical relevance to the existing FUZKK catalog.
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Representative manufacturing and QC chain
- 1Route development, raw materials and scale-up
- 2Synthesis, bioprocessing or formulation development
- 3Purification, filtration, drying or aseptic processing
- 4Technology transfer, cleaning and change control
- 5HPLC/GC/KF/ICP/LC-MS and method-validation evidence
- 6Cell bank or microbial seed
- 7Upstream culture or fermentation
- 8Clarification and chromatography
- 9UF/DF, formulation and sterile filtration
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerElemental Impurities ICP Quality CheckerLC-MS Confirmation Quality CheckerBiologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality Checker
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Methodology